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Abstract
While spinal interbody cage options have proliferated in the past decade, relatively little work has been done to explore the
comparative potential of biomaterial technologies in promoting stable fusion. Innovations such as micro-etching and nanoarchitectural designs have shown purported beneﬁts in in vitro studies, but lack clinical data describing their optimal
implementation. Here, we critically assess the pre-clinical data supportive of various commercially available interbody cage
biomaterial, topographical, and structural designs. We describe in detail the osteointegrative and osteoconductive beneﬁts
conferred by these modiﬁcations with a focus on polyetheretherketone (PEEK) and titanium (Ti) interbody implants. Further,
we describe the rationale and design for two randomized controlled trials, which aim to address the paucity of clinical data
available by comparing interbody fusion outcomes between either PEEK or activated Ti lumbar interbody cages. Utilizing
dual-energy computed tomography (DECT), these studies will evaluate the relative implant-bone integration and fusion rates
achieved by either micro-etched Ti or standard PEEK interbody devices. Taken together, greater understanding of the
relative osseointegration proﬁle at the implant–bone interface of cages with distinct topographies will be crucial in guiding
the rational design of further studies and innovations.
Graphical Abstract
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Solid bony fusion is an essential requirement for successful
spinal arthrodesis surgery that allows for stability of adjacent vertebrae [1–4]. A complex balance of biological and
mechanical factors is at play during interbody fusion following cage implantation [5]. Interbody cages are most
commonly composed of either polyetheretherketone
(PEEK) or titanium (Ti) [6]. While PEEK can cause a local
inﬂammatory response that can interfere with osseous
integration, solid titanium cages overcome this concern but
alternatively can induce mismatch in the elastic modulus
[7–11]. The use of both Ti and PEEK in clinical practice is
limited by delayed and incomplete integration with adjacent
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bony surfaces following implantation. The recent development of novel porous cages has been guided by the goals of
accelerating osseointegration of the cage to the adjacent
vertebrae and thus reducing motion by enhancing the fusion
of the cage at the interface with the bone [12, 13].
Enhancements to implant topography and architecture,
including surface treatments and porous technologies, can
putatively accelerate osseointegration and osteoconduction,
which is key to long-term biomechanical function of
interbody devices [11, 14, 15]. Further, interlaced lattice or
scaffold designs can mimic cancellous bone structure
through a microscopic porous implant–bone interface that
can promote osteogenesis and bony fusion over the longterm [16–18]. Such complex lattice geometric designs and
ability to scaffold biomaterial cannot be typically created by
traditional manufacturing processes and are dependent on
sophisticated 3DP technologies [17, 19, 20].
The purpose of this article is to critically assess the
tissue engineering potential of modiﬁed implant surfaces in
spinal surgery, in particular with respect to the ability of
activated surface and scaffold designs to accelerate or
enhance osseointegration and structural stability following
spinal instrumented arthrodesis procedures. We review a
new imaging modality, dual-energy computed tomography
(DECT), which allows for additional image postprocessing and material characterization not possible with
conventional systems. Finally, we discuss the rationale for
two recently initiated randomized clinical trials designed to
evaluate the rate of early osseous fusion using DECT
within either activated Ti or PEEK lumbar interbody cages.
Taken together, we believe that new insights will soon be
gained to help elucidate the potential relative efﬁcacy of
microscopic lattice structures in accelerating the process of
osseointegration and fusion.

2 Cage topography and enhanced
osseointegration
While current lumbar interbody cage designs are generally
associated with favorable radiologic and clinical outcomes
[21–23], full bony integration is not always observed and is
often delayed, in particular with concomitant smoking,
older age, or immunosuppressant use [24–26]. Furthermore,
given that mechanical loads regulate bone remodeling and
maintenance, stress-shielding due to implant-bone stiffness
mismatch can lead to eventual interface failure [27]. To
overcome this limitation, novel technologies can take
advantage of designing implants with more favorable
mechanical and molecular properties, thus more closely
resembling physiologic trabecular bone patterning.
A recent in vitro evaluation showed that implants
bearing a trabecular scaffolded topography enhance cellular

proliferation, bone matrix formation, and mineralization
with increased mechanical strength by 20% for compression
strength and 60% for compressive modulus [17]. Further,
these implants exhibit expedited cellular proliferative
activity as well as increased extracellular matrix production
and ~50% higher calcium production as compared to standard templates [28, 29]. While these early studies are suggestive of potential efﬁcacy, well-designed clinical studies
will ultimately be required to conﬁrm whether implant
microstructure can serve as a more effective medium to
support healing and osseous fusion [30].
One critical implant property that can play a role in
osteoconduction and osseointegration is the threedimensional geometry and intricately designed porosity.
Speciﬁcally, interbody cage porosity accommodates bone
ingrowth with the potential to yield improved implant
ﬁxation [27, 31]. A minimum pore size of 100 μm is more
conducive to bony ingrowth than sizes less than 75 μm,
while pore sizes over 300 μm further enhance the osteogenic
response [32, 33]. In a transcortical rabbit study, increasing
pore sizes from 100 to 300 μm not only increased bony
integration within the pores of titanium alloy implants but
also enhanced the percentage of lamellar bone that was
produced [18]. Another study in sheep compared a porous
titanium cage (with median 68% porosity and 710 μm pore
size) to the standard PEEK cage. The porous titanium
cage promoted enhanced osseointegration and achieved
more rapid bone growth [34]. In yet another ovine study,
3DP porous titanium cages demonstrated increases in bone
ingrowth as compared with solid PEEK and plasma-sprayed
porous Ti-coated PEEK [16]. The beneﬁcial impact of
adding porosity to the implant is not limited to Ti, as porous
PEEK cages have also been shown to enhance osseointegration [35, 36]. In vitro evaluation has conﬁrmed favorable
attachment, proliferation, and mineralization of cells cultured on porous PEEK versus either smooth PEEK or
smooth Ti surfaces [36]. At the implant level, in vivo studies have identiﬁed comparable bone ingrowth into porous
PEEK as that previously reported for porous Ti, leading to
twice the ﬁxation strength as compared to smooth PEEK
implants [36].
Implant surface roughness and surface ﬁnish also may
play a signiﬁcant role in promoting osseointegration [37].
An early study showed that a roughened surface having Ra
measurements ranging from 5.0 to 11.8 was attained via a
surface-blasting process with the effect of increasing overall
bone-implant contact, on the surface and within the pores
[18]. Further work has revealed that ‘microroughness’
inﬂuences the types of integrins that are produced by the
cells at the interface, promoting those subunits associated
with bone proteins, such as α2 and β1, but not those subunits associated with soft tissue proteins, such as α5 or αv.
Thus, microroughness can affect the progression of the
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Fig. 1 Pictures of Activated Ti and PEEK interbody cages used in
Trial 1 and 2 (left and right) along with their respective surface contact
characteristics. For Trial 1, considering 34 mm length × 10 mm width
(6° lordotic) Ti and PEEK implants, comparable graft and cage

endplate contact areas (ECAs) are noted. Similarly for Trial 2, considering 26–28 mm length × 10 mm width Ti and PEEK implants,
comparable graft and cage ECAs are also noted

osteoblast phenotype by up‐regulating speciﬁc integrins that
directly regulate osteoblast differentiation and local factor
production [38]. Most recently, nanostructured surfaces, i.e.
those containing irregularities less than 100 nm, have been
posited to more faithfully mimic the nanoarchitecture of
natural tissues [39, 40].
Another study compared osseointegration when alumina and a multiphase calcium phosphate (MCD) were
used as the blast media. Blasted Ti alloy (Ti6Al4V)
cylinders were implanted into rabbit tibiae and then evaluated two and four weeks after implantation. The histologic results showed the MCD to elicit signiﬁcantly greater
volume of new bone formation [41]. A more recent study
demonstrated that increased surface roughness enhances
in vitro osteoblast maturation and production of local
factors associated with osteogenesis and in vivo that the
same topographies increase bone‐to‐implant contact and
torque removal forces [42].
Intriguingly, the combination of nanostructures onto
microroughened surfaces may synergistically enhance the
production of osteoblast differentiation markers and local
factors important for bone formation compared to unmodiﬁed
microrough controls [43]. Indeed, osteoblasts have been
shown to exhibit a more differentiated phenotype when
cultured on Ti6Al4V surfaces with a microtopography that
includes submicron and nanoscale features [44].
Yet another factor that can inﬂuence the biomimetic
properties of the bone–implant interface is the modulus of
elasticity. Speciﬁcally, 3DP can design implants with an
elasticity modulus resembling natural or cadaveric tissue.
As a result, a better elastic recovery, biodegradability and
cytocompatibility is expected [45, 46]. Moreover, implants
with modiﬁed elasticity modulus also show enhanced
mechanical characteristics in compression and shear when
compared with standard designs, resulting in better
device–tissue interface and biocompatibility [47].
A number of activated Ti cages are commercially
available but with no long-term clinical evidence supporting

their relative efﬁcacy in promoting early osseointegration
and fusion [48, 49]. A recent prospective study evaluated
novel 3DP interbody devices in 40 patients (total of
53 segments) undergoing posterolateral interbody fusion
(PLIF) procedures. Bone fusion results were promising with
94.3%, 86.7%, and 94.3% of interbody segments showing
complete anterior, posterior, and bilateral bone bridges on
sagittal and coronal computed tomography (CT) views,
respectively. No pseudarthrosis was noted and no revision
surgeries were required [50]. Finally, while the potential
beneﬁts of accelerated osseointegration and bony fusion are
particularly relevant for patients with anticipated compromised bone fusion (such as elderly patients with osteoporosis, or with concomitant tobacco or immunosuppressant
use), no controlled studies have yet been undertaken.

3 Rationale and design of RCTs
Clinical conﬁrmation of enhanced osseointegration or
bony fusion through activated Ti cages remains lacking.
As such, the principal author (HFF) has designed two
separate randomized double-arm single-blinded studies in
patients undergoing either single- or double-level instrumented arthrodesis procedures (Trial 1: NCT0364751,
Trial 2: clinical trials.gov submission in progress) to
compare radiologic and clinical outcomes using either
activated Ti cages (Trial 1: banana-shaped Nexxt Spine
Matrix® or Trial 2: straight-shaped Medtronic AdaptixTM)
versus PEEK cages.
Both Ti cages have hollow centers and are characterized
by similar cage, graft, and total endplate contact areas to the
respective PEEK cages (see Fig. 1). Both cages also
incorporate proprietary macro- and nano-scale biomimetic
surface texturing that both promote initial ﬁxation and bone
remodeling required for osseointegration. The architecture
of the cage in Trial 1 further incorporates a lattice that
provides a consistent 70% porosity and an interconnected
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describe the Fraser deﬁnition of locked pseudoarthrosis
(BSF scale) with a Grade BSF-3 being considered successful bone fusion. Grade BSF-3 is deﬁned by radiographical fusion presenting bone bridges within at least half
of the fusion area with at least the density originally
achieved at surgery (see Table 1) [51–53].

Fig. 2 Appearance of titanium cage on dual-energy CT (DECT)
imaged in a synthetic polyurethane foam/ hydroxyapatite lumbar spine
model. a Axial and (b) sagittal reformatted 100 keV virtual monochromatic images (VMIs) reconstructed from a DECT scan of the
spine show that the lattice portion has high density (arrowheads) but
that is less than the solid titanium portions (marked by the arrows). The
center is hollow (asterisks). Scan acquired using a rapid kV-switching
CT scanner (Revolution CT, GE Healthcare)
Table 1 Radiographic assessment of interbody fusion by the method
of Brantigan, Steffee, and Fraser (BSF)[53]
BSF-1: Radiographical pseudarthrosis is indicated by collapse of the
construct, loss of disc height, vertebral slip, broken screws,
displacement of the carbon cage, or signiﬁcant resorption of the bone
graft, or lucency visible around the periphery of the graft or cage.
BSF-2: Radiographical locked pseudarthrosis is indicated by lucency
visible in the middle of the cages with solid bone growing into the
cage from each vertebral endplate.
BSF-3: Radiographical fusion: bone bridges at least half of the fusion
area with at least the density originally achieved at surgery.
Radiographical fusion through one cage (half of the fusion area) is
considered to be mechanically solid fusion even if there is lucency
on the opposite side.

array of 300–700μm pores with two speciﬁc geometries; the
inferior/superior surfaces incorporate a square mesh
between the exterior structural frame while the lateral
aspects employ a coupled hexagon-diamond mesh. Both
lattice geometries were designed so that the resulting pore
sizes would range from 300–700 μm, which is a dimensional geometry purported to be conducive to osseointegration. The appearance of the Trial 1 Ti interbody cage on
CT is shown in Fig. 2.
Starting in August 2018, enrolled subjects have been
randomized to receive either an activated Ti or PEEK cage
(Trial 1) implanted at each level of single- or contiguous
double-level lumbar arthrodesis procedures. Both cages will
be used in conjunction with milled local autograft bone
generated as part of the spinal decompression portion of the
procedure. Clinical and radiographic outcomes are being
collected at regular intervals post-operatively. The primary
outcome measure of effectiveness is radiographic bony
fusion as assessed by an independent neuroradiologist at
6 months post-operatively, which grossly corresponds to the
early phase of expected fusion following lumbar interbody
cage placement. Radiographic bone fusion will be graded
by the method of Brantigan and Steffee as modiﬁed to

4 Radiologic evaluation with dual-energy CT
Patients enrolled in these trials will be assessed with an
advanced form of CT, called DECT [54–59]. While a
detailed discussion is beyond the scope of this article, a
brief review will be provided to illustrate the potential of
DECT to achieve new insights in imaging of spinal fusion
with cages. DECT confers the same advantages as conventional, single-energy CT (SECT) such as rapid scan
acquisition times, a high spatial resolution, and the ability to
demonstrate and evaluate ﬁne bone detail. However, DECT
also enables additional image post-processing and material
characterization not possible with conventional CT systems.
With SECT, a polychromatic beam at one peak energy is
emitted by the X-ray tube, passes through the patient, and
the attenuation data are captured by a detector array. With
DECT, attenuation data are instead obtained separately at
both a low and a high energy. In this fashion, the data are
combined and can be processed to generate images or
evaluate tissue characteristics in unique ways, taking
advantage of energy-dependent attenuation (i.e. density or
brightness on CT) of different tissues (Fig. 3).
Unlike with current X-ray tube technology where greater
artifact is expected with a polychromatic beam, DECT can
generate virtual monochromatic images (VMIs) (Figs. 2–4)
[54–59]. Using sophisticated algorithms, the scanned data at
different energies are combined to generate images at a
range of prescribed X-ray energy levels and thus simulate
what would be expected with a monochromatic X-ray beam.
VMI energies that can be generated with current DECT
systems typically range between 40 and 140 keV (Fig. 3),
with VMIs of 65–70 keV generally considered similar to
120 keV on standard acquisition [60–62].
With current X-ray tube technology, it is not possible to
generate monochromatic spectra for scanning and greater
artifact is expected with a polychromatic beam. As such, the
potential for diminished artifact stems from the ability of
VMIs to simulate what would be expected with a monochromatic X-ray beam. Furthermore, VMI images can be
generated at a wide range of energies with unique advantages
depending on the problem at hand and material of interest
(Fig. 3). By generating VMIs at energies higher than those
typically used to simulate a standard acquisition, one can
reduce artifact arising from metallic hardware [63–67]
(see Fig. 4). This is clearly of interest in imaging of the
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Fig. 3 Example of energy-dependent density (attenuation) changes of
the titanium cage lattice using dual-energy CT (DECT). a Axial image
demonstrates two regions of interest (ROIs) with the corresponding (b)
spectral Hounsﬁeld Unit attenuation curves (SHUACs). ROIs are used
to obtain quantitative information from the image. The small circles
represent the ROIs (to which the arrows point) and correspond to the
regions where the measurements were obtained. The information
obtained from the ROIs is illustrated in the corresponding SHUACs,

which demonstrate the changes in material density at various virtual
monochromatic image (VMI) energies. By way of comparison with
conventional single energy CT acquisition, there would only be a
single attenuation per ROI, typically corresponding to that obtained on
the 65–70 keV VMIs. Thus, DECT allows the energy-dependent
characteristics of various materials to be exploited to improve diagnostic evaluation. Scan acquired using a rapid kV-switching CT
scanner (Revolution CT, GE Healthcare)

Fig. 4 High energy virtual monochromatic image (VMI) reconstructions allow for artifact reduction. Axial (a) 70 keV, (b) 100 keV, and
(c) 140 keV VMIs reconstructed from the same dual-energy CT
(DECT) scan are shown. The images are displayed using the same
window-level display settings to enable a direct and unbiased comparison. Note the signiﬁcant reduction in artifact and image noise on

the high energy VMIs at 100 keV (b) or 140 keV (c) compared to the
70 keV VMI (a), which is typically considered to correspond to the
conventional single energy CT scan. Of note, the images shown
here are the qualitative correlates of the attenuation measurements
shown in Fig. 3

instrumented spine and the primary motivation for using
DECT for patient follow-up in these two trials.
Finally, DECT scans can be used to generate basis
material decomposition maps. While the feasibility depends
on the speciﬁc material of interest and its physical properties, these maps can be used to estimate the distribution and
concentration of certain materials, which is not possible
using conventional CT imaging. One such example, virtual
non-calcium maps, are used to demonstrate marrow edema
[64, 68, 69]. In contrast to conventional SECT, multiple
studies have demonstrated that DECT can demonstrate
marrow edema with high accuracy, improving detection of
subtle ﬁndings such as non-displaced fractures [68]. Thus,
in addition to the use of different energy VMIs, one can
exploit DECT to improve visualization of bony fusion
beyond artifact reduction alone. For example, one can
leverage the material speciﬁc energy-dependent properties
and create DECT maps that are tailored for tracking and
demonstrating osseointegration within a cage lattice using

basis material decomposition. Since all of the above are
post-processing maneuvers based on the source data
acquired at the time of DECT scanning and do not require
any additional patient scanning or radiation exposure, they
represent exciting additional applications that will be
investigated during the course of these trials.

5 Conclusions
Enhanced implant-bone integration and fusion rates may
have signiﬁcant clinical beneﬁts, particularly in more
complicated clinical scenarios where fusion may be
delayed, such as in osteoporosis, smokers, or with concomitant immunosuppressant use. The results of these two
trials should provide relevant information regarding the
relative efﬁcacy of activated Ti surfaces (without or with a
supplemental lattice network) in accelerating the process of
osseointegration and fusion. Novel insights in this regard
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are likely to be gained with DECT imaging, whose potential
advantages include enhanced artifact reduction. Our conclusions should also assist in the design of further multicenter studies evaluating potential clinical beneﬁts, either
for similar degenerative conditions or for more complex
reconstructions such as in adult spinal deformity.
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